surmount-osa trial tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized Tirzepatide in Obesity-Related Obstructive Sleep
Pay in 4 interest-free payments of $6.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31























:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)





